Six-Month Visual Outcomes in Pediatric Optic Neuritis: A Multicenter Study From South Korea
Abstract
Background:: Current knowledge regarding the causes, clinical course, treatment response, and long-term outcomes of pediatric optic neuritis remains largely derived from case reports and retrospective series. Considering the ethnic variability in its presentation and the critical role of antibody-based differential diagnoses in guiding treatment strategies, further research is necessary. The aim of this study was to provide insights into the etiology and clinical findings of pediatric optic neuritis, thereby improving our knowledge of the condition in the era of antibody-based approaches.
Methods:: This prospective multicenter cohort study was conducted at 31 referral medical centers. Patients younger than 18 years with first-episode optic neuritis were included. All patients underwent comprehensive neuro-ophthalmic examinations, including aquaporin-4–IgG and myelin oligodendrocyte glycoprotein–IgG testing and brain/orbit MRI. The primary outcome measure was best-corrected visual acuity (BCVA) at 6 months. Best-corrected visual acuity was further categorized into high vision (BCVA ≥ 20/40), moderate vision (20/200 < BCVA < 20/40), and low vision (BCVA ≤ 20/200).
Results:: Overall, 44 pediatric patients were enrolled, with a mean age at onset of 10.7 ± 3.5 years. Bilateral optic neuritis and optic disc swelling were observed in 56.8% and 81.8% of patients, respectively. The mean BCVA at enrolment was 0.99 ± 0.89 logMAR, which improved significantly to 0.24 ± 0.52 logMAR at 6 months. The final 6-month diagnoses included myelin oligodendrocyte glycoprotein antibody–associated disease (n = 30 [68.2%]), isolated optic neuritis (n = 11 [25.0%]), acute disseminated encephalomyelitis (n = 2 [4.5%]), multiple sclerosis (n = 1 [2.3%]). No patients had neuromyelitis optica. At the 6-month follow-up, 50.0% showed improvement in the visual category, 50.0% maintained their visual category, and none experienced deterioration. There were no significant predictors related to poor BCVA at enrolment and at 6 months.
Conclusion:: Pediatric optic neuritis exhibits severe visual deficits but shows good recovery. Myelin oligodendrocyte glycoprotein antibody–associated disease is the most common etiology. These findings reflect the distinct characteristics of pediatric optic neuritis and provide important baseline data for developing tailored treatment strategies.
Related
- A Prospective, Observational, Open-Label, Nonrandomized, Multicenter Study Measuring Functional Outcomes in a Novel Interspinous Stabilization Device in Patients With Low Back Pain: 12-Month Results for the REFINE Study
- A Response to “Magnitude of Visual Recovery at 12 Months After Optic Neuritis: Beyond Visual Acuity in a Thai Tertiary-Care Cohort” [Letter]
- Short-Term Macular Structural Changes and 3-Month Visual Outcomes After Cataract Surgery in Patients with Type 2 Diabetes: Associations with Preoperative HbA1c and OCT Findings
- Factors associated with delayed diagnosis from first psychiatric consultation and its relationship with 9-month symptom outcomes in bipolar disorder: a multicenter study in China
- Visual, refractive and patient-reported outcomes after two trifocal intraocular lens designs: a 12-month comparative cohort study.
BibTeX
@article{joo2026sixmonth,
title = {{Six-Month Visual Outcomes in Pediatric Optic Neuritis: A Multicenter Study From South Korea}},
author = {Hye Jun Joo and Jae Ryong Song and Byung Chan Lim and Won Jae Kim and Mi Young Choi and Haeng-Jin Lee and Seung Ah Chung and Dong Gyu Choi and Hye Young Kim and Young-Woo Suh and Hyuna Kim and Joo Yeon Lee and Bo Young Chun and Ungsoo Samuel Kim and Hwan Heo and Hae Ri Yum and Eun Hee Hong and Jae Ho Jung and Seong-Joon Kim},
journal = {Journal of Neuro-Ophthalmology},
year = {2026},
month = jun,
doi = {10.1097/wno.0000000000002474},
url = {https://doi.org/10.1097/wno.0000000000002474},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Six-Month Visual Outcomes in Pediatric Optic Neuritis: A Multicenter Study From South Korea
AU - Hye Jun Joo
AU - Jae Ryong Song
AU - Byung Chan Lim
AU - Won Jae Kim
AU - Mi Young Choi
AU - Haeng-Jin Lee
AU - Seung Ah Chung
AU - Dong Gyu Choi
AU - Hye Young Kim
AU - Young-Woo Suh
AU - Hyuna Kim
AU - Joo Yeon Lee
AU - Bo Young Chun
AU - Ungsoo Samuel Kim
AU - Hwan Heo
AU - Hae Ri Yum
AU - Eun Hee Hong
AU - Jae Ho Jung
AU - Seong-Joon Kim
PY - 2026
DA - 2026/06/01
JO - Journal of Neuro-Ophthalmology
DO - 10.1097/wno.0000000000002474
UR - https://doi.org/10.1097/wno.0000000000002474
AB - Background:: Current knowledge regarding the causes, clinical course, treatment response, and long-term outcomes of pediatric optic neuritis remains largely derived from case reports and retrospective series. Considering the ethnic variability in its presentation and the critical role of antibody-based differential diagnoses in guiding treatment strategies, further research is necessary. The aim of this study was to provide insights into the etiology and clinical findings of pediatric optic neuritis, thereby improving our knowledge of the condition in the era of antibody-based approaches. Methods:: This prospective multicenter cohort study was conducted at 31 referral medical centers. Patients younger than 18 years with first-episode optic neuritis were included. All patients underwent comprehensive neuro-ophthalmic examinations, including aquaporin-4–IgG and myelin oligodendrocyte glycoprotein–IgG testing and brain/orbit MRI. The primary outcome measure was best-corrected visual acuity (BCVA) at 6 months. Best-corrected visual acuity was further categorized into high vision (BCVA ≥ 20/40), moderate vision (20/200 < BCVA < 20/40), and low vision (BCVA ≤ 20/200). Results:: Overall, 44 pediatric patients were enrolled, with a mean age at onset of 10.7 ± 3.5 years. Bilateral optic neuritis and optic disc swelling were observed in 56.8% and 81.8% of patients, respectively. The mean BCVA at enrolment was 0.99 ± 0.89 logMAR, which improved significantly to 0.24 ± 0.52 logMAR at 6 months. The final 6-month diagnoses included myelin oligodendrocyte glycoprotein antibody–associated disease (n = 30 [68.2%]), isolated optic neuritis (n = 11 [25.0%]), acute disseminated encephalomyelitis (n = 2 [4.5%]), multiple sclerosis (n = 1 [2.3%]). No patients had neuromyelitis optica. At the 6-month follow-up, 50.0% showed improvement in the visual category, 50.0% maintained their visual category, and none experienced deterioration. There were no significant predictors related to poor BCVA at enrolment and at 6 months. Conclusion:: Pediatric optic neuritis exhibits severe visual deficits but shows good recovery. Myelin oligodendrocyte glycoprotein antibody–associated disease is the most common etiology. These findings reflect the distinct characteristics of pediatric optic neuritis and provide important baseline data for developing tailored treatment strategies.
SN - 1070-8022
SN - 1536-5166
ER -